Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen Wins Approval for Long-Lasting Hemophilia B Treatment
Biogen Wins Approval for Long-Lasting Hemophilia B Treatment
Biogen Wins Approval for Long-Lasting Hemophilia B Treatment
Submitted by
admin
on March 29, 2014 - 9:10am
Source:
Bloomberg
News Tags:
Biogen Idec
Alprolix
hemophilia
hemophilia B
Headline:
Biogen Wins Approval for Long-Lasting Hemophilia B Treatment
Do Not Allow Advertisers to Use My Personal information
